TABLE 2.
Clinical characteristics of ovarian cancer survivors
| Ovarian cancer (N = 1689) (n [%]) | |
|---|---|
| Diagnosis year | |
| 1996–1999 | 369 (21.9) |
| 2000–2004 | 401 (23.7) |
| 2005–2009 | 382 (22.6) |
| 2010–2012 | 537 (31.8) |
| Age at diagnosis | |
| <40 | 144 (8.53) |
| 40–49 | 240 (14.2) |
| 50–59 | 377 (22.3) |
| 60–69 | 365 (21.6) |
| 70–79 | 363 (21.5) |
| 80+ | 200 (11.8) |
| Cancer stage | |
| Local | 295 (17.5) |
| Regional | 253 (15.0) |
| Distant | 1141 (67.6) |
| Histology | |
| High‐grade serous | 873 (51.7) |
| Low‐grade serous | 17 (1.0) |
| Endometrioid | 143 (8.5) |
| Mucinous | 115 (6.8) |
| Clear cell | 94 (5.6) |
| Carcinosarcoma | 38 (2.3) |
| Carcinoma, NOS | 245 (14.5) |
| Other a | 164 (9.7) |
| Treatment | |
| Surgery only | 448 (26.5) |
| Radiation only | 60 (3.6) |
| Chemotherapy only | 155 (9.2) |
| Surgery and chemotherapy | 803 (47.5) |
| Other b | 16 (1.0) |
| No treatment | 207 (12.3) |
a
Including Malignant Brenner, Mixed, Non‐specific.
b
Including combination of radiation and surgery, combination of radiation and chemotherapy.